Caffeine withdrawal increases cerebral blood flow velocity and alters quantitative electroencephalography (EEG) activity
- PMID: 10672630
- DOI: 10.1007/s002130050005
Caffeine withdrawal increases cerebral blood flow velocity and alters quantitative electroencephalography (EEG) activity
Abstract
Rationale: Cessation of daily caffeine consumption produces a withdrawal syndrome comprised of subjective symptoms and functional impairment. Few controlled studies have examined the physiological effects of caffeine withdrawal.
Objective: The present study examined the effect of caffeine withdrawal on cerebral blood flow velocity and quantitative EEG.
Methods: Ten volunteers reporting moderate caffeine intake (mean 333 mg/day) participated in this double-blind study. Subjects completed several tests when maintaining their normal diet (baseline period) and during two 1-day periods during which they consumed caffeine-free diets and received capsules containing placebo (placebo test session) or caffeine (caffeine test session) in amounts equal to their baseline daily caffeine consumption. Blood flow velocity was determined for four arteries: right and left middle (MCA), and right and left anterior (ACA) cerebral arteries using pulsed transcranial Doppler sonography. EEG was recorded for 3 min from eight scalp sites while subjects sat, with eyes closed, in a sound-attenuated electronically shielded chamber. Subjective effects were assessed with questionnaires.
Results: Results showed an effect of the placebo (21-h withdrawal) condition compared to the caffeine condition. Placebo significantly increased the mean velocity, systolic velocity and diastolic velocity (cm/s) in all four cerebral arteries. In the MCA, the pulsatility index was significantly decreased following placebo. Placebo significantly increased EEG theta power. Placebo also produces subjective effect changes, including increases in heavy feelings in arms and legs and decreases in ability to concentrate. The caffeine and baseline conditions produced similar results on both the physiological and subjective measures.
Conclusion: Cessation of daily caffeine consumption produced changes in cerebral blood flow velocity and quantitative EEG. These changes may be related to classic caffeine withdrawal symptoms of headache, drowsiness and decreased alertness.
Similar articles
-
Caffeine withdrawal, acute effects, tolerance, and absence of net beneficial effects of chronic administration: cerebral blood flow velocity, quantitative EEG, and subjective effects.Psychopharmacology (Berl). 2009 Jul;204(4):573-85. doi: 10.1007/s00213-009-1489-4. Epub 2009 Feb 25. Psychopharmacology (Berl). 2009. PMID: 19241060 Free PMC article. Clinical Trial.
-
Effects of dietary caffeine on topographic EEG after controlling for withdrawal and withdrawal reversal.Neuropsychobiology. 2007;56(4):197-207. doi: 10.1159/000120625. Epub 2008 Mar 13. Neuropsychobiology. 2007. PMID: 18337638 Clinical Trial.
-
Withdrawal syndrome after the double-blind cessation of caffeine consumption.N Engl J Med. 1992 Oct 15;327(16):1109-14. doi: 10.1056/NEJM199210153271601. N Engl J Med. 1992. PMID: 1528206 Clinical Trial.
-
A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features.Psychopharmacology (Berl). 2004 Oct;176(1):1-29. doi: 10.1007/s00213-004-2000-x. Epub 2004 Sep 21. Psychopharmacology (Berl). 2004. PMID: 15448977 Review.
-
Caffeine, sleep and wakefulness: implications of new understanding about withdrawal reversal.Hum Psychopharmacol. 2007 Dec;22(8):549-58. doi: 10.1002/hup.881. Hum Psychopharmacol. 2007. PMID: 17868185 Review.
Cited by
-
Repeated caffeine intake suppresses cerebral grey matter responses to chronic sleep restriction in an A1 adenosine receptor-dependent manner: a double-blind randomized controlled study with PET-MRI.Sci Rep. 2024 Jun 3;14(1):12724. doi: 10.1038/s41598-024-61421-8. Sci Rep. 2024. PMID: 38830861 Free PMC article. Clinical Trial.
-
The effect of EEG and fNIRS in the digital assessment and digital therapy of Alzheimer's disease: a systematic review.Front Neurosci. 2023 Nov 21;17:1269359. doi: 10.3389/fnins.2023.1269359. eCollection 2023. Front Neurosci. 2023. PMID: 38075282 Free PMC article. Review.
-
Blood-brain barrier permeability in response to caffeine challenge.Magn Reson Med. 2022 Nov;88(5):2259-2266. doi: 10.1002/mrm.29355. Epub 2022 Jun 26. Magn Reson Med. 2022. PMID: 35754146 Free PMC article.
-
Bibliometric Analysis of Quantitative Electroencephalogram Research in Neuropsychiatric Disorders From 2000 to 2021.Front Psychiatry. 2022 May 23;13:830819. doi: 10.3389/fpsyt.2022.830819. eCollection 2022. Front Psychiatry. 2022. PMID: 35677873 Free PMC article.
-
Time to Recover From Daily Caffeine Intake.Front Nutr. 2022 Feb 2;8:787225. doi: 10.3389/fnut.2021.787225. eCollection 2021. Front Nutr. 2022. PMID: 35187019 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials